Sulfatides: Targets for Anti-Phospholipid Antibodies

Circulation

Volumn 108, Issue 17, 2003, Pages 2082-2087

  Merten, M ^a   Motamedy, S ^a   Ramamurthy, S ^b   Arnett, F C ^b   Thiagarajan, Perumal ^a,b,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Antibodies; Coagulation; Glycoproteins; Sulfatides

Indexed keywords

BETA2 GLYCOPROTEIN 1; BETA2 GLYCOPROTEIN 1 ANTIBODY; PHOSPHOLIPID ANTIBODY; SULFATIDE;

ANTIBODY TITER; ANTIGEN RECOGNITION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CLINICAL ARTICLE; HUMAN; IMMUNOPATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; THROMBOGENESIS;

ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; CARDIOLIPINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOPROTEINS; HUMANS; IMMUNOSORBENT TECHNIQUES; LIPOSOMES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MACROMOLECULAR SUBSTANCES; PROTEIN BINDING; SJOGREN'S SYNDROME; SULFOGLYCOSPHINGOLIPIDS;

EID: 0242349755     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000095030.44185.6A     Document Type: Article

References (24)

1. Ishizuka I. Chemistry and functional distribution of sulfoglycolipids. Prog Lipid Res. 1997;36:245-319.
2. Zhu X, Hara A, Taketomi T. The existence of galactosylceramide 3-sulfate in serums of various mammals and its anticoagulant activity J Biochem. 1991;110:241-245.
3. Andrews RK, Booth WJ, Bendall LJ, et al. The amino acid sequence glutamine-628 to valine-646 within the Al repeat domain mediates binding of von Willebrand factor to bovine brain sulfatides and equine tendon collagen. Platelets. 1995;6:245-251.
4. Roberts D, Haverstick DM, Dixit VM, et al. The platelet glycoprotein thrombospondin binds specifically to sulfated glycolipids. J Biol Chem. 1985;260:9405-9411.
5. Aruffo A, Kolanus W, Walz G, et al. CD62/P-selection recognition of myeloid and tumor cell sulfatides. Cell. 1991;67:35-44.
6. Needham LK, Schnaar RL. The HNK-1 reactive sulfoglucuronyl glycolipids are ligands for L-selectin and P-selectin but not E-selectin. Proc Natl Acad Sci U S A. 1993;90:1359-1363.
7. Roberts DD, Rao CN, Liotta LA, et al. Comparison of the specificities of laminin, thrombospondin, and von Willebrand factor for binding to sulfated glycolipids. J Biol Chem. 1986;261:6872-6877.
8. Espana F, Ratnoff OD. Activation of Hageman factor (factor XII) by sulfatides and other agents in the absence of plasma proteases. J Lab Clin Med. 1983;102:31-45.
9. Tans G, Rosing J, Griffin JH. Sulfatide-dependent autoactivation of human blood coagulation factor XII (Hageman factor). J Biol Chem. 1983;258:8215-8222.
10. Lozier J, Takahaski N, Putnam FW. Complete amino acid sequence of human plasma beta2-glycoprotein 1. Proc Natl Acad Sci U S A. 1984;81:3640-3644.
11. Kato H, Enyoji K. Amino acid sequence and location of the disulfide bonds in bovine beta 2 glycoprotein I: the presence of five Sushi domains. Biochemistry. 1991;30:11687-11694.
12. Chonn A, Semple SC, Cullis PR. Association of blood proteins with large unilamellar liposomes in vivo: relation to circulation lifetimes. J Biol Chem. 1992;267:18759-18765.
13. McNeil HP, Simpson RJ, Chesterman CN, et al. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A. 1990;87:4120-4124.
14. Galli M, Comfurius P, Maassen C, et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet. 1990;335:1544-1547.
15. Thiagarajan P, Le A, Benedict CR. Beta(2)-glycoprotein I promotes the binding of anionic phospholipid vesicles by macrophages. Arterioscler Thromb Vasc Biol. 1999;19:2807-2811.
16. Chong CS, Colbow K. Light scattering and turbidity measurements on lipid vesicles. Biochim Biophys Acta. 1976;436:260-282.
17. Pengo V, Thiagarajan P, Shapiro SS, et al. Immunological specificity and mechanisms of action of IgG lupus anticoagulants. Blood. 1987;70:69-76.
18. Nimpf J, Bevers EM, Bomans PHH. Prothrombinase activity of human platelets is inhibited by beta 2-glycoprotein-I. Biochim Biophys Acta. 1986;884:142-149.
19. Merten M, Thiagarajan P. Role for sulfatides in platelet aggregation. Circulation. 2001;104:2955-2960.
20. Wurm H. Beta 2-glycoprotein-I (apolipoprotein H) interactions with phospholipid vesicles. Int J Biochem. 1984;16:511-515.
21. Balasubramanian K, Schroit AJ. Characterization of phosphatidylserine-dependent beta2-glycoprotein I macrophage interactions: implications for apoptotic cell clearance by phagocytes. J Biol Chem. 1998;273:29272-29277.
22. Thiagarajan P, Shapiro SS. Lupus anticoagulants and antiphospholipid antibodies. Hematol Oncol Clin North Am. 1998;12:1167-1192.
23. Galli M, Luciani D, Bertolini G, et al. Lupus anticoagulants are stronger risk factors of thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood. 2003;101:1827-1823.
24. Takamatsu K. Phytosphingosine-containing neutral glycosphingolipids and sulfatides in the human female genital tract: their association in the cervical epithelium and the uterine endometrium and their dissociation in the mucosa of fallopian tube with the menstrual cycle. Keio J Med. 1992;41:161-167.